Biodiesel has emerged as a promising renewable and clean energy alternative to petrodiesel. While biodiesel has traditionally been prepared through homogeneous basic catalysis, heterogeneous acid catalysis has been investigated recently due to its ability to convert cheaper but high free fatty acid content oils such as waste vegetable oil while decreasing production cost. In this work, the esterification of free fatty acid over sulfated zirconia and activated acidic alumina in a batch reactor was considered. The models of the reaction over the catalysts were developed in two parts. First, a kinetic study was performed using a deterministic model to develop a suitable kinetic expression; the related parameters were subsequently estimated by numerical techniques. Second, a stochastic model was developed to further confirm the nature of the reaction at the molecular level. The esterification of palmitic acid obeyed the Eley-Rideal mechanism in which palmitic acid and methanol are adsorbed on the surface for SO?/ZrO?-550°C and AcAl?O? respectively. The coefficients of determination of the deterministic model were 0.98, 0.99 and 0.99 for SO?/ZrO?-550°C at 40, 60 and 80°C respectively and 0.99, 0.98 and 0.96 for AcAl?O? at the same temperature. The deterministic and stochastic models were in good agreement. / Master of Science

No / Background Oral administration of the omega-3 fatty acid eicosapentaenoic acid (EPA), as the free fatty acid (FFA), leads to EPA incorporation into, and reduced growth of, experimental colorectal cancer liver metastases (CRCLM). Design: We performed a Phase II double-blind, randomised, placebo-controlled trial of EPA-FFA 2 g daily in patients undergoing liver resection surgery for CRCLM. The patients took EPA-FFA (n=43) or placebo (n=45) prior to surgery. The primary end-point was the CRCLM Ki67 proliferation index (PI). Secondary end-points included safety and tolerability of EPA-FFA, tumour fatty acid content and CD31-positive vascularity. We also analysed overall survival (OS) and disease-free survival (DFS). Results The median (range) duration of EPA-FFA treatment was 30 (12–65) days. Treatment groups were well matched with no significant difference in disease burden at surgery or preoperative chemotherapy. EPA-FFA treatment was well tolerated with no excess of postoperative complications. Tumour tissue from EPA-FFA-treated patients demonstrated a 40% increase in EPA content (p=0.0008), no difference in Ki67 PI, but reduced vascularity in ‘EPA-naïve’ individuals (p=0.075). EPA-FFA also demonstrated antiangiogenic activity in vitro. In the first 18 months after CRCLM resection, EPA-FFA-treated individuals obtained OS benefit compared with placebo, although early CRC recurrence rates were similar. Conclusions EPA-FFA therapy is safe and well tolerated in patients with advanced CRC undergoing liver surgery. EPA-FFA may have antiangiogenic properties. Remarkably, limited preoperative treatment may provide postoperative OS benefit. Phase III clinical evaluation of prolonged EPA-FFA treatment in CRCLM patients is warranted. Trial Identifier: ClinicalTrials.gov NCT01070355. / The Cancer Research UK Clinical Trials Awards and Advisory Committee approved the Trial. PML and ADR were supported by Department of Health/Cancer Research UK Yorkshire Experimental Cancer Medicine Centre funding. The Trial was adopted by the UKCRN Clinical Trials Portfolio (UKCRN ID 8946) allowing West Yorkshire Comprehensive Local Research Network funding of Pharmacy costs. SLA Pharma AG funded some of the experimental work and provided EPA-FFA and placebo. SLA Pharma AG played no role in the design or execution of the Trial. Laboratory costs were also supported by the Leeds Teaching Hospitals Charitable Foundation (Rays of Hope).

No / Inflammatory bowel diseases are associated with increased risk of developing colitis-associated colorectal cancer (CAC). Epidemiological data show that the consumption of ω-3 polyunsaturated fatty acids (ω-3 PUFAs) decreases the risk of sporadic colorectal cancer (CRC). Importantly, recent data have shown that eicosapentaenoic acid-free fatty acid (EPA-FFA) reduces polyp formation and growth in models of familial adenomatous polyposis. However, the effects of dietary EPA-FFA are unknown in CAC. We tested the effectiveness of substituting EPA-FFA, for other dietary fats, in preventing inflammation and cancer in the AOM-DSS model of CAC. The AOM-DSS protocols were designed to evaluate the effect of EPA-FFA on both initiation and promotion of carcinogenesis. We found that EPA-FFA diet strongly decreased tumor multiplicity, incidence and maximum tumor size in the promotion and initiation arms. Moreover EPA–FFA, in particular in the initiation arm, led to reduced cell proliferation and nuclear β-catenin expression, whilst it increased apoptosis. In both arms, EPA-FFA treatment led to increased membrane switch from ω-6 to ω-3 PUFAs and a concomitant reduction in PGE2 production. We observed no significant changes in intestinal inflammation between EPA-FFA treated arms and AOM-DSS controls. Importantly, we found that EPA-FFA treatment restored the loss of Notch signaling found in the AOM-DSS control and resulted in the enrichment of Lactobacillus species in the gut microbiota. Taken together, our data suggest that EPA-FFA is an excellent candidate for CRC chemoprevention in CAC.

Ce travail a pour objectif d'étudier les effets d’une supplémentation en acides gras polyinsaturés (AGPI) n-3 à longues chaines sur la production d’embryons chez les vaches laitières. Le régime enrichi en AGPI n-3 a eu tendance à augmenter le nombre moyen des complexes ovocyte-cumulus récupérés par vache par session d’OPU par rapport au groupe témoin AGPI n-6. Une tendance à augmenter le nombre moyen par vache par session d’OPU de blastocystes et de blastocystes expansés avec une augmentation significative de blastocystes de qualité 1 et 2 ont été notés dans le groupe n-3. De même, les taux de blastocystes, de blastocystes expansés et de blastocystes de qualité 1 et 2 ont été significativement augmentés dans le groupe n-3. Nous avons aussi montré que l’addition d’acide docosahexaénoïque (DHA, C22:6 n-3) à une faible concentration (1μM) pendant la maturation in vitro des ovocytes bovins augmente significativement le taux de clivage et le taux et la qualité de blastocyste. La stimulation de FFAR4 (free fatty acid receptor 4), au cours de la MIV, par un agoniste spécifique (TUG 891), a entrainé des effets bénéfiques similaires à ceux du DHA (1μM) sur la compétence ovocytaire. Cela suggère que l’effet bénéfique du DHA pourrait passer, au moins partiellement, par l’activation du FFAR4. / We aimed to investigate whether dietary n-3 PUFA, in Prim‘Holstein dairy cattle in lactation, could influence reproductive performance in terms of embryo production. We showed that n-3 PUFA-enriched diet had a tendency to increase the average number of oocyte-cumulus complexes recovered per cow per OPU session. A tendency to increase the average numbers per cow per OPU session of blastocysts and expanded blastocysts with significantly increase of blastocysts of quality 1 and 2 were noted in the n-3 group compared to the n-6 group. Similarly, the rate of blastocysts, expanded blastocysts and blastocysts of quality 1 and 2 were significantly increased in the n-3 group compared to the n-6 group. We also showed that the addition of docosahexaenoic acid (DHA, C22:6 n-3) at low concentration (1μM) during IVM of bovine oocytes increased cleavage rate, blastocyst rate and embryo quality. DHA and free fatty acid receptor 4 (FFAR4) agonist TUG- 891 (1 or 5 μM) supplied during IVM similarly improved in vitro embryo development, suggesting that FFAR4 may, at least partially, mediate DHA beneficial effects on OCC, through activation of signaling pathways.

No description available.

Fatty acid amide hydrolase (FAAH) is a widely conserved amidase in eukaryotes, best known for inactivating the signal of N-acylethanolamine (NAE) lipid mediators. In the plant Arabidopsis thaliana, FAAH-mediated hydrolysis of NAEs has been associated with numerous biological processes. Recently, the phylogenetic distribution of FAAH into two major branches (group I and II FAAHs) across angiosperms outside of Arabidopsis (and in other Brassicaceae), suggests a previously unrecognized complexity of this enzyme. Although A. thaliana has long been used to assess biological questions for plants, in this case it will fall short in understanding the significance of multiple FAAHs in other plant systems. Thus, in this study, I examined the role (s) of six FAAH isoforms in upland cotton (Gossypium hirsutum L.) and two FAAHs in the legume Medicago truncatula.

Made available in DSpace on 2014-07-29T15:22:57Z (GMT). No. of bitstreams: 1 Ana Carolina borges.pdf: 467440 bytes, checksum: 24a6d8fa920ce0c5e39df74c7d7f523f (MD5) Previous issue date: 2008-02-07 / This study aimed to assess: the manufacture of Pecorino cheese from cow's milk, income from manufacturing of cheeses, lipolysis and proteolysis during the maturation, preference and acceptance of cheeses and characterize the Pecorino cheese, milk, cow, after 45 days of maturation. Pecorino cheeses were produced by three treatments: no lipase, with lipase of kid and with lipase of kid and lamb. It was examined the income of manufacturing in L/ kg, the coefficient GL, L / kg adjusted and the figures the transfer of components of milk to the cheese. It was found that the addition of lipase didn t influence in income. The income from the manufacture of Pecorino cheese found was 8.05 L / kg, 8.22 L / kg adjusted, 61.25 gST / L e 76.34%, 93.00% and 50.57%, the figures for transfer of protein, fat and total dry extract, respectively. It was found that the humidity decreased and dry extract increased, the pH increased at the start and then had a slight decline, the salt content in moisture, nitrogen soluble at pH 4.6, the non-protein nitrogen in the rates of extension and depth of maturity increased over the 45 days of maturity. Adding the milk lipases influenced the increase in the rate of acid free fatty acids in Pecorino cheese. At the fortieth fifth day of maturation there was significant difference between the rates of acidity of the AGL Pecorino cheeses of all treatments. The index of acidity of AGL of Pecorino cheese containing lipase of kid and lamb was higher than that of Pecorino cheese containing lipase of kid, which in turn was higher than the rate of acidity of AGL of Pecorino cheese without lipase. The cheeses with 45 days of ripening, presented the following composition: 33.41% of moisture, 66.59% of total dry extract, 33.26% of dry extract defatted, 25.51% of protein, 33.33 % of fat, 50.05% of fat in the dry extract, 2.20% of sodium chloride, 6.17% of salt in moisture, pH 5.49, the water activity of 0.850. The preference and acceptance of the cheeses were evaluated at the 45 days of maturity. Cheese without lipase and added lipase of kid were more preferred (p <0.05) by the judges in relation to the cheese added of lipase of kid and lamb. The addition of lipase from kid and lamb in the milk interfered (p <0.05) in the acceptance and preference of Pecorino cheese from cow's milk, with 45 days of ripening, making it with strong flavor. The Pecorino cheese without lipase was more accepted (p <0.05) than the other two treatments containing lipase, but the Pecorino cheese of all treatments were well accepted. / O presente trabalho teve como objetivo avaliar: a fabricação de queijos Pecorino com leite de vaca, o rendimento de fabricação dos queijos produzidos, a proteólise e lipólise ao longo da maturação, a preferência e aceitação dos queijos produzidos e caracterizar o queijo Pecorino com leite de vaca, após 45 dias de maturação. Foram produzidos queijos Pecorino em três tratamentos: sem lipase, com lipase de cabrito e com lipase de cabrito e cordeiro. Foi analisado o rendimento das fabricações em L/kg, coeficiente GL, L/kg ajustado e pelas cifras de transferência dos componentes do leite para o queijo. Foi verificado que a adição de lipase não influenciou o rendimento. O rendimento da fabricação dos queijos Pecorino encontrado foi de 8,05 L/kg, 8,22 L/kg ajustado, 61,25 gST/L e 76,34%, 93,00% e 50,57%, de cifras de transferência de proteína, de gordura e de extrato seco total, respectivamente. Foi verificado que a umidade diminuiu e o extrato seco aumentou, o pH aumentou no início e depois teve uma ligeira queda, o teor de sal na umidade, o nitrogênio solúvel a pH 4,6, o nitrogênio nãoprotéico e os índices de extensão e profundidade de maturação aumentaram ao longo dos 45 dias de maturação. A adição das lipases ao leite influenciou o aumento do índice de acidez de ácidos graxos livres nos queijos Pecorino. Ao quadragésimo quinto dia de maturação houve diferença significativa entre os índices de acidez de AGL dos queijos Pecorino de todos os tratamentos. O índice de acidez de AGL dos queijos Pecorino adicionados de lipase de cabrito e cordeiro foi maior do que o dos queijos Pecorino adicionados de lipase de cabrito, que por sua vez, foi maior do que o índice de acidez de AGL dos queijos Pecorino sem lipase. Os queijos com 45 dias de maturação, apresentaram a seguinte composição: 33,41%, de umidade, 66,59% de extrato seco total, 33,26%, de extrato seco desengordurado, 25,51% de proteína, 33,33% de gordura, 50,05% de gordura no extrato seco, 2,20% de cloreto de sódio, 6,17% de sal na umidade, pH 5,49, atividade de água de 0,850. A preferência e aceitação dos queijos foram avaliadas, aos 45 dias de maturação. Os queijos sem lipase e adicionados de lipase de cabrito foram mais preferidos (p<0,05) pelos provadores em relação ao queijo adicionado de lipase de cabrito e cordeiro. A adição da lipase de cabrito e cordeiro ao leite interferiu (p<0,05) na aceitação e preferência do queijo Pecorino com leite de vaca, com 45 dias de maturação, tornando-o com sabor forte. O queijo Pecorino sem lipase foi mais aceito (p<0,05) do que os outros dois tratamentos adicionados de lipase, mas os queijos Pecorino de todos os tratamentos foram bem aceitos.

Les maladies métaboliques, comme le diabète, la dyslipidémie ou l’obésité, constituent un problème majeur de santé publique dans les pays développés. Ces maladies très répandues restent encore difficiles à traiter malgré une recherche active. Les stratégies thérapeutiques contre ces maladies incluent le développement de nouvelles molécules ciblant les récepteurs aux acides gras, étant donné leur rôle essentiel dans l’homéostasie du métabolisme. C’est dans ce contexte que s’inscrit ce travail portant sur deux récepteurs couplés aux protéines G, les récepteurs aux acides gras à courte chaîne 2 et 3 ou free fatty acid receptors 2 (FFA2) et 3 (FFA3). Nous avons tout d'abord cherché à déterminer le profil d'expression des deux récepteurs. Ensuite, nous avons établi des lignées cellulaires stable exprimant FFA2 ou FFA3 afin d’étudier la pharmacologie d’agonistes synthétiques et endogènes de ces récepteurs. Après avoir identifié les voies de signalisation engendrées par l’activation des récepteurs, nous avons démontré que les agonistes synthétiques étaient des activateurs allostériques, c’est-à-dire qu’ils se liaient aux récepteurs sur un site distinct de celui des ligands endogènes. Pour identifier les résidus d’acides aminés nécessaires à la reconnaissance des ligands, nous avons généré une gamme de mutants ponctuels de ces récepteurs par mutagénèse dirigée. En analysant l’effet des mutations dans des tests fonctionnels, nous avons pu déterminer avec précision où se liaient les ligands et ainsi pu dessiner par informatique des modèles structuraux des récepteurs qui pourront être utilisés pour le drug design de futures molécules agonistes de ces récepteurs. / Metabolic diseases, such as diabetes, dyslipidemia or obesity, are more and more weighing on public health expenses in developed countries. Despite active research, these widespread diseases remain difficult to handle. Promising new therapeutic strategies against metabolic diseases include the development of drugs targeting the free fatty acid receptors, as key players in metabolism homeostasis. In this context, the current PhD thesis focuses on the study of two G protein-coupled receptors, namely the short-chain free fatty acid receptors 2 (FFA2) and 3 (FFA3). First, we investigated the expression of the two receptors of interest in a variety of cell types. Then, in order to study the pharmacology and the binding mode of endogenous and synthetic agonists on FFA2 and FFA3, we established stable cell lines expressing each receptor. Once we identified the signaling pathways engendered in response to receptor activation, we showed that synthetic agonists were allosteric activators of the receptors, in the sense that they bind to the receptors at a distinct site from short-chain fatty acids, i.e. the endogenous agonists. To identify the aminoacid residues that were involved in ligand binding, we generated a variety of point mutated receptors by site-directed mutagenesis. By analyzing the effects of the mutations in functional tests, we determined precisely the aminoacid residues that were essential for ligand binding. From these results, we designed in silico structural models which may aid future drug design efforts for the discovery of new FFA2 and FFA3 agonists.

Einleitung: Ruminal werden Futterpflanzen zu kurzkettigen Fettsäuren (SCFAs) abgebaut. Diese bilden die Hauptenergiequelle für den Wiederkäuerorganismus. Da diese Fettsäuren jedoch auch maßgeblich die pH-Homöostase der Vormagenschleimhaut beeinflussen, muss das Pansenepithel in der Lage sein, Änderungen im Substrat- und Protonenangebot festzustellen und anschließend regulative Prozesse anzupassen, um Stoffwechselentgleisungen und so auch einer Pansenazidose vorzubeugen. In anderen Spezies erwiesen sich sogenannte „Freie Fettsäurerezeptoren“ (FFARs) als potenzielle Sensoren veränderter SCFA-Mengen im Darmlumen, die u. a. durch Modulation der intrazellulären Spiegel an zyklischem Adenosinmonophosphat (cAMP) ihre Wirkung vermitteln. Ziele der Untersuchungen: Es sollte in der vorliegenden Arbeit untersucht werden, ob FFARs im Pansenepithel des Schafes vorkommen und durch SCFAs aktiviert sowie intrazelluläre Signalwege über cAMP moduliert werden können. Im Anschluss sollte erarbeitet werden, inwiefern der nachgewiesene Einfluss von Butyrat auf die epithelialen cAMP-Spiegel Auswirkungen auf die epitheliale pH-Modulation infolge einer veränderten Aktivität von Monocarboxylattransportern (MCTs) und Na+/H+-Austauschern (NHEs) hat. Tiere, Material und Methoden: Sämtliche Untersuchungen wurden an Geweben des Vormagens von Schafen (Ovis gmelini aries) durchgeführt. Mittels Reverse-Transkriptase-Polymerase-Kettenreaktion (RT-PCR) und immunhistochemischer Färbungen wurde das Vorliegen verschiedener FFARs in nativem Pansengewebe untersucht. Zur funktionellen Charakterisierung wurden Epithelstücke aus dem ventralen Pansensack in Ussing-Kammern inkubiert und anschließend die cAMP-Spiegel im Epithel mittels einer quantitativen, kompetitiven Analyse bestimmt. Dabei wurde der Einfluss von Forskolin (ein Stimulator der cAMP-synthetisierenden Adenylylzyklasen), von Butyrat sowie von Niacin (ein FFAR-Agonist) betrachtet. Mithilfe von radioaktiv markiertem Azetat wurde der Effekt variierender cAMP-Spiegel auf die Transportaktivität von MCTs unter Zuhilfenahme von zwei verschiedenen MCT-Hemmstoffen (Cyanohydroxyzimtsäure und p-Hydroxymercuribenzoesäure) in Ussing-Kammern evaluiert. Die Aktivität der NHEs wurde an kultivierten Pansenepithelzellen durch Messung des intrazellulären pH-Wertes mittels Spektrofluorometrie unter Einfluss des NHE-Inhibitors 5-N-Ethyl-N-Isopropyl Amilorid ermittelt. Auch hierbei wurden in den Zellen unterschiedliche cAMP-Spiegel durch Forskolin-Applikation induziert. Die Daten der verschiedenen Untersuchungen wurden an 5-8 Tieren je Versuchsansatz erhoben. Die Normalverteilung wurde mittels Kolmogorov–Smirnov-Test ermittelt. Ein Friedman-Test mit anschließendem Dunn-Test wurde für die Analyse der cAMP-Experimente genutzt. MCT und NHE Experimente wurden mithilfe einer einfachen, geblockten Varianzanalyse und anschließendem Tukey-Test ausgewertet. Ergebnisse: Die FFARs GPR109A und FFAR2 konnten an allen untersuchten Lokalisationen (Netzmagen, Pansenvorhof, dorsaler und ventraler Pansensack, Psalter) über RT-PCR bzw. im ventralen Pansensack auch über die immunhistochemischen Färbungen detektiert werden, wohingegen FFAR3 lediglich als mRNA im Vorhof nachweisbar war. Dies lässt die beiden Rezeptoren GPR109A und FFAR2 als mögliche Strukturen zur Detektion von SCFAs im Pansenepithel erscheinen. Die Analyse der intrazellulären cAMP-Spiegel in Epithelien aus dem ventralen Pansensack konnte einen hemmenden Einfluss von Butyrat auf diesen Botenstoff darlegen, was auf eine Beteiligung der genannten FFARs hindeutet. Die Applikation des GPR109A-Agonisten Niacin hatte jedoch keinen Effekt auf die cAMP-Spiegel, sodass eine Wirkungsvermittlung von Butyrat über diesen Rezeptor unwahrscheinlich scheint. Mit Blick auf die funktionellen Auswirkungen dieser cAMP-Modulation hatten variierende cAMP-Level im Kontrast zu Erkenntnissen aus Nicht-Wiederkäuerspezies keinen Einfluss auf die Transportaktivität des ruminalen MCT1 unter den gewählten in vitro-Versuchsbedingungen. Andererseits konnte die Regulation des intrazellulären pH-Wertes von kultivierten Pansenepithelzellen tendenziell durch erhöhte cAMP-Spiegel gehemmt werden, was auf einer Hemmung von NHEs durch den second messenger beruhen könnte. Schlussfolgerungen: Die Expression von GPR109A und FFAR2 lassen diese zwei FFARs als potenzielle Sensoren der intraruminalen bzw. intraepithelialen Nährstoffkonditionen erscheinen. Dabei deuten die vorliegenden Untersuchungen auf eine Aktivierung des FFAR2 durch Butyrat und dessen Metaboliten in den basalen Schichten des Pansenepithels hin. Infolge der Rezeptoraktivierung kommt es vermutlich zu einer Verminderung der intraepithelialen cAMP-Spiegel, welche wiederum einen (schwachen) Einfluss auf die Regulation des intrazellulären pH-Wertes mithilfe von NHEs zu haben scheinen. Entgegen unserer Ausgangshypothese scheinen aber die FFARs des ovinen Pansenepithels die pH-Homöostase des Epithels nur geringfügig zu beeinflussen. Ihre genaue physiologische Bedeutung – insbesondere des GPR109A – bleibt somit noch spekulativ.:1 Einleitung 1 2 Literaturübersicht 3 2.1 Bedeutung kurzkettiger Fettsäuren für den Wiederkäuer 3 2.2 Transport kurzkettiger Fettsäuren über das Pansenepithel 3 2.2.1 Apikale Aufnahme in das Pansenepithel 4 2.2.2 Basolaterale Ausschleusung in den Blutstrom 6 2.3 Metabolisierung kurzkettiger Fettsäuren im Pansenepithel 8 2.4 pH-Homöostase 9 2.4.1 pH-Regulation des Pansenlumens 9 2.4.2 pH-Regulation des Pansenepithels 10 2.5 Anpassungsmechanismen des Pansenepithels 12 2.6 Rolle des Butyrats 15 2.7 Fettsäurerezeptoren 16 2.7.1 G-Protein-gekoppelte Rezeptoren 17 2.7.2 GPRs für SCFAs 17 2.7.2.1 FFAR2 17 2.7.2.2 FFAR3 18 2.7.2.3 GPR109A 19 2.7.3 FFARs im Wiederkäuerorganismus 20 2.8 Monocarboxylattransporter 22 2.8.1 Die Familie der MCTs 22 2.8.2 Regulation der MCTs 23 2.8.3 MCTs im Pansenepithel 24 2.9 Natrium-Protonen-Austauscher 26 2.9.1 Die Familie der NHEs 26 2.9.2 Regulation der NHEs 27 2.9.3 NHEs im Pansenepithel 28 2.10 Fragestellungen der vorliegenden Arbeit 30 3 Publikationen 32 3.1 Publikation 1 32 3.2 Publikation 2 41 3.2.1 Supporting Information 56 4 Diskussion 57 4.1 Nachweis von FFARs im Pansenepithel 57 4.1.1 Regulation intrazellulärer Signalwege durch FFARs 59 4.1.2 GPR109A als potenzieller Butyrat-Rezeptor im Pansenepithel 62 4.1.3 FFAR2 als potenzieller Rezeptor für Butyrat 63 4.2 Seitenabhängigkeit der Butyrat-Effekte 64 4.3 pH-Abhängigkeit der cAMP-Spiegel 66 4.4 Einfluss von cAMP auf die Aktivität der MCTs 68 4.5 Einfluss von cAMP auf die NHE-Aktivität 70 4.6 Schlussfolgerungen 73 5 Zusammenfassung 75 6 Summary 77 7 Literaturverzeichnis 79 8 Anhang 101 8.1 Im Rahmen dieser Dissertation gehaltene Präsentationen 101 Danksagung 103 / Introduction: Forage plants are ruminally degraded to short chain fatty acids (SCFAs). These serve as the main energy source for ruminants. As SCFAs also influence the pH-homeostasis of the ruminal mucosa, the epithelium must be able to detect changes of both substrate and proton accumulation and adapt transport processes accordingly, in order to prevent metabolic dysfunction and thus the risk of ruminal acidosis. Studies in non-ruminant species detected so-called ‘free fatty acid receptors’ (FFARs) as potential SCFA-sensors in the gut lumen. It has been shown that these receptors transduce their information by modulation of intracellular levels of cyclic adenosine monophosphate (cAMP). Aim: This study intended to investigate if FFARs are located in the ovine ruminal epithelium. It should further be evaluated if FFARs can be stimulated by SCFAs leading to a modulation of intracellular pathways via cAMP. Finally, the study aimed to elucidate the influence of low epithelial cAMP-levels after butyrate application on the regulation of pH-homeostasis in the ruminal epithelium by modulating the activity of transport proteins such as monocarboxylate transporters (MCTs) and Na+/H+ exchangers (NHEs). Animals, material, and methods: All experiments were conducted with ovine (Ovis aries) ruminal tissues. The expression of different FFARs was investigated in native tissues using a reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining. For functional analysis, epithelial cAMP levels were determined by a quantitative and competitive assay after incubation of epithelia of the ruminal ventral sac in Ussing chambers. The influence of forskolin (a stimulator of the adenylyl cyclases), butyrate, as well as niacin (an FFAR agonist) was evaluated. Further, the effect of varying cAMP levels on transport activity of MCTs was characterised on Ussing chamber-mounted epithelia with radioactively labelled acetate and two MCT inhibitors (cyano-hydroxycinnamic acid and p-hydroxymercuribenzoic acid). Finally, the activity of NHEs was assessed in cultured ruminal epithelial cells. The intracellular pH was evaluated by spectrofluorometry while the cells were incubated with forskolin (to modify intracellular cAMP levels) or the NHE inhibitor 5-(N-ethyl-N-isopropyl)-amiloride. The data for the different set-ups were acquired from 5-8 animals each. Kolmogorov–Smirnov test was used for testing normality. For cAMP level analyses, the Friedman test followed by Dunn's test was performed. MCT and NHE measurements were analysed using one-way randomized block analysis of variance followed by Tukey's test. Results: GPR109A and FFAR2 were detected in all ovine ruminal epithelia examined (reticulum, atrium ruminis, ruminal ventral and dorsal sac, omasum) by RT-PCR and in ruminal ventral sac also by immunohistochemical staining. FFAR3, however, was detected solely on mRNA level in tissues of the ovine atrium ruminis. Thus, the two immunohistochemically detected receptors may serve as potential sensors for SCFAs in the ruminal epithelium. The analysis of intraepithelial cAMP levels revealed an inhibiting influence of butyrate application on cAMP pointing to an activation of FFARs by this SCFA. Nonetheless, the incubation with the GPR109A agonist niacin did not show any effect on cAMP levels. This finding contradicts the theory of an activation of GPR109A by butyrate. Looking at functional consequences of varying cAMP levels, in contrast to studies on non-ruminant species ruminal MCT1 activity was not influenced by different cAMP levels, at least under the conditions chosen in this in vitro study. However, regulation of intracellular pH in cultured ruminal epithelial cells tended to decrease with augmented cAMP levels. This might be mediated by an inhibition of NHEs. Conclusions: The expression of GPR109A and FFAR2 points at a participation of these receptors in sensing intraruminal and intraepithelial energy status. The present data hint at an activation of FFAR2 by butyrate or its metabolites in the basal layers of the epithelium. Activation of the receptor leads to decreased cAMP levels. This in turn seems to slightly modify the regulation of intracellular pH via NHEs. Contradicting our initial hypothesis, ovine ruminal FFARs seem to play only a minor role in modulation of epithelial pH homeostasis. The main physiological role of ruminal FFARs – especially of GPR109A – remains to be clarified.:1 Einleitung 1 2 Literaturübersicht 3 2.1 Bedeutung kurzkettiger Fettsäuren für den Wiederkäuer 3 2.2 Transport kurzkettiger Fettsäuren über das Pansenepithel 3 2.2.1 Apikale Aufnahme in das Pansenepithel 4 2.2.2 Basolaterale Ausschleusung in den Blutstrom 6 2.3 Metabolisierung kurzkettiger Fettsäuren im Pansenepithel 8 2.4 pH-Homöostase 9 2.4.1 pH-Regulation des Pansenlumens 9 2.4.2 pH-Regulation des Pansenepithels 10 2.5 Anpassungsmechanismen des Pansenepithels 12 2.6 Rolle des Butyrats 15 2.7 Fettsäurerezeptoren 16 2.7.1 G-Protein-gekoppelte Rezeptoren 17 2.7.2 GPRs für SCFAs 17 2.7.2.1 FFAR2 17 2.7.2.2 FFAR3 18 2.7.2.3 GPR109A 19 2.7.3 FFARs im Wiederkäuerorganismus 20 2.8 Monocarboxylattransporter 22 2.8.1 Die Familie der MCTs 22 2.8.2 Regulation der MCTs 23 2.8.3 MCTs im Pansenepithel 24 2.9 Natrium-Protonen-Austauscher 26 2.9.1 Die Familie der NHEs 26 2.9.2 Regulation der NHEs 27 2.9.3 NHEs im Pansenepithel 28 2.10 Fragestellungen der vorliegenden Arbeit 30 3 Publikationen 32 3.1 Publikation 1 32 3.2 Publikation 2 41 3.2.1 Supporting Information 56 4 Diskussion 57 4.1 Nachweis von FFARs im Pansenepithel 57 4.1.1 Regulation intrazellulärer Signalwege durch FFARs 59 4.1.2 GPR109A als potenzieller Butyrat-Rezeptor im Pansenepithel 62 4.1.3 FFAR2 als potenzieller Rezeptor für Butyrat 63 4.2 Seitenabhängigkeit der Butyrat-Effekte 64 4.3 pH-Abhängigkeit der cAMP-Spiegel 66 4.4 Einfluss von cAMP auf die Aktivität der MCTs 68 4.5 Einfluss von cAMP auf die NHE-Aktivität 70 4.6 Schlussfolgerungen 73 5 Zusammenfassung 75 6 Summary 77 7 Literaturverzeichnis 79 8 Anhang 101 8.1 Im Rahmen dieser Dissertation gehaltene Präsentationen 101 Danksagung 103